These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34895657)

  • 21. Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory.
    Cowan AD; Ciulli A
    Annu Rev Biochem; 2022 Jun; 91():295-319. PubMed ID: 35320687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Branched ubiquitin code: from basic biology to targeted protein degradation.
    Ohtake F
    J Biochem; 2022 Mar; 171(4):361-366. PubMed ID: 35037035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cereblon-dependent targeted protein degrader by visualizing the spatiotemporal ternary complex formation in cells.
    Kaji T; Koga H; Kuroha M; Akimoto T; Hayata K
    Sci Rep; 2020 Feb; 10(1):3088. PubMed ID: 32080280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation.
    Oleinikovas V; Gainza P; Ryckmans T; Fasching B; Thomä NH
    Annu Rev Pharmacol Toxicol; 2024 Jan; 64():291-312. PubMed ID: 37585660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted protein degradation: Emerging concepts and protein state-specific targeting principles.
    Tao AJ; Gadbois GE; Buczynski SA; Ferguson FM
    Curr Opin Chem Biol; 2022 Apr; 67():102114. PubMed ID: 35042023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted protein degradation: from mechanisms to clinic.
    Tsai JM; Nowak RP; Ebert BL; Fischer ES
    Nat Rev Mol Cell Biol; 2024 Sep; 25(9):740-757. PubMed ID: 38684868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biophysical and Computational Approaches to Study Ternary Complexes: A 'Cooperative Relationship' to Rationalize Targeted Protein Degradation.
    Ward JA; Perez-Lopez C; Mayor-Ruiz C
    Chembiochem; 2023 May; 24(10):e202300163. PubMed ID: 37018140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic and Structural Features of PROTAC Ternary Complexes.
    Casement R; Bond A; Craigon C; Ciulli A
    Methods Mol Biol; 2021; 2365():79-113. PubMed ID: 34432240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of targeted protein degradation therapeutics.
    Chamberlain PP; Hamann LG
    Nat Chem Biol; 2019 Oct; 15(10):937-944. PubMed ID: 31527835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
    Guharoy M; Bhowmick P; Tompa P
    J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perilous journey: a tour of the ubiquitin-proteasome system.
    Kleiger G; Mayor T
    Trends Cell Biol; 2014 Jun; 24(6):352-9. PubMed ID: 24457024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system.
    Liu J; Dong S; Li L; Wang H; Zhao J; Zhao Y
    Cell Signal; 2019 Jun; 58():91-98. PubMed ID: 30849519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. F-box protein Fbxo3 targets Smurf1 ubiquitin ligase for ubiquitination and degradation.
    Li D; Xie P; Zhao F; Shu J; Li L; Zhan Y; Zhang L
    Biochem Biophys Res Commun; 2015 Mar; 458(4):941-5. PubMed ID: 25721664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function.
    Heilingloh CS; Mühl-Zürbes P; Steinkasserer A; Kummer M
    J Gen Virol; 2014 Jun; 95(Pt 6):1366-1375. PubMed ID: 24643878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics.
    Simard JR; Lee L; Vieux E; Improgo R; Tieu T; Phillips AJ; Fisher SL; Pollock RM; Park E
    SLAS Discov; 2021 Apr; 26(4):503-517. PubMed ID: 33430712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes.
    Schiemer J; Horst R; Meng Y; Montgomery JI; Xu Y; Feng X; Borzilleri K; Uccello DP; Leverett C; Brown S; Che Y; Brown MF; Hayward MM; Gilbert AM; Noe MC; Calabrese MF
    Nat Chem Biol; 2021 Feb; 17(2):152-160. PubMed ID: 33199914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.
    Alchanati I; Teicher C; Cohen G; Shemesh V; Barr HM; Nakache P; Ben-Avraham D; Idelevich A; Angel I; Livnah N; Tuvia S; Reiss Y; Taglicht D; Erez O
    PLoS One; 2009 Dec; 4(12):e8104. PubMed ID: 19956605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.
    Nguyen HC; Wang W; Xiong Y
    Subcell Biochem; 2017; 83():323-347. PubMed ID: 28271482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploiting Ubiquitin Ligases for Induced Target Degradation as an Antiviral Strategy.
    Verma R
    Adv Exp Med Biol; 2021; 1322():339-357. PubMed ID: 34258747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted protein degradation mechanisms.
    Zhang Y; Loh C; Chen J; Mainolfi N
    Drug Discov Today Technol; 2019 Apr; 31():53-60. PubMed ID: 31200860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.